Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SANDOZ LESCOL CONSUMER COST SHOULD BE AROUND $1 PER DAY

Executive Summary

SANDOZ LESCOL CONSUMER COST SHOULD BE AROUND $1 PER DAY for the once-daily cholesterol-lowering agent, resulting in savings of "several hundred dollars" a year for the "typical patient" if he or she switches to Lescol, the company said. When it becomes available in April, Lescol (fluvastatin) will be the fourth HMG- CoA reductase inhibitor on the market and will be priced 42% to 49% lower than the three competing products: Merck's Mevacor and Zocor and Bristol-Myers Squibb's Pravachol.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS024234

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel